Show simple item record

dc.contributor.authorWolffsohn, JS
dc.contributor.authorKollbaum, PS
dc.contributor.authorBerntsen, DA
dc.contributor.authorAtchison, DA
dc.contributor.authorBenavente, A
dc.contributor.authorBradley, A
dc.contributor.authorBuckhurst, H
dc.contributor.authorCollins, M
dc.contributor.authorFujikado, T
dc.contributor.authorHiraoka, T
dc.contributor.authorHirota, M
dc.contributor.authorJones, D
dc.contributor.authorLogan, NS
dc.contributor.authorLundstrom, L
dc.contributor.authorTorii, H
dc.contributor.authorRead, SA
dc.contributor.authorNaidoo, K
dc.date.accessioned2019-03-26T16:52:37Z
dc.date.available2019-03-26T16:52:37Z
dc.date.issued2019-02
dc.identifier.issn0146-0404
dc.identifier.issn1552-5783
dc.identifier.urihttp://hdl.handle.net/10026.1/13545
dc.description.abstract

The evidence-basis based on existing myopia control trials along with the supporting academic literature were reviewed; this informed recommendations on the outcomes suggested from clinical trials aimed at slowing myopia progression to show the effectiveness of treatments and the impact on patients. These outcomes were classified as primary (refractive error and/or axial length), secondary (patient reported outcomes and treatment compliance), and exploratory (peripheral refraction, accommodative changes, ocular alignment, pupil size, outdoor activity/lighting levels, anterior and posterior segment imaging, and tissue biomechanics). The currently available instrumentation, which the literature has shown to best achieve the primary and secondary outcomes, was reviewed and critiqued. Issues relating to study design and patient selection were also identified. These findings and consensus from the International Myopia Institute members led to final recommendations to inform future instrumentation development and to guide clinical trial protocols.

dc.format.extentM132-M160
dc.format.mediumPrint
dc.languageen
dc.language.isoen
dc.publisherAssociation for Research in Vision and Ophthalmology
dc.subjectmyopia control
dc.subjectmyopia progression
dc.subjectclinical trial guidelines
dc.subjectinstrumentation
dc.subjectrecommendations
dc.titleIMI - Clinical Myopia Control Trials and Instrumentation Report
dc.typejournal-article
dc.typeArticle
plymouth.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000460128100007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue3
plymouth.volume60
plymouth.publisher-urlhttp://dx.doi.org/10.1167/iovs.18-25955
plymouth.publication-statusPublished
plymouth.journalInvestigative Ophthalmology & Visual Science
dc.identifier.doi10.1167/iovs.18-25955
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/School of Health Professions
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Health and Community
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dc.publisher.placeUnited States
dcterms.dateAccepted2018-10-20
dc.rights.embargodate2019-12-18
dc.identifier.eissn1552-5783
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1167/iovs.18-25955
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2019-02
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV